0,977  0,001  TRPA1 agonist
0,868  0,008  Antiinflammatory
0,863  0,005  CYP2C9 substrate
0,852  0,002  Antihypotensive
0,832  0,003  Angiogenesis stimulant
0,801  0,004  Myocardial infarction treatment
0,801  0,013  Transcription factor NF kappa B inhibitor
0,780  0,001  Vanilloid 1 agonist
0,770  0,002  Vanilloid agonist
0,770  0,011  Teratogen
0,733  0,007  Sensitization
0,733  0,012  Embryotoxic
0,719  0,005  Antiepileptic
0,700  0,007  Bone diseases treatment
0,688  0,006  Antiosteoporotic
0,679  0,004  UGT1A4 substrate
0,703  0,030  Apoptosis agonist
0,673  0,005  Antiglaucomic
0,675  0,007  Spasmolytic
0,670  0,005  Psychostimulant
0,668  0,010  CYP2C19 substrate
0,656  0,004  Antialcoholic
0,650  0,005  Antianorexic
0,644  0,017  Alzheimer's disease treatment
0,639  0,014  Antibacterial
0,621  0,011  Stroke treatment
0,619  0,015  Chemoprotective
0,607  0,010  NOS2 expression inhibitor
0,597  0,008  Antineurogenic pain
0,586  0,005  Monophenol monooxygenase inhibitor
0,579  0,005  Diabetic retinopathy treatment
0,582  0,012  Antiparasitic
0,584  0,015  Immunosuppressant
0,553  0,008  UGT1A1 substrate
0,550  0,008  Antineoplastic (endocrine cancer)
0,556  0,015  Antioxidant
0,538  0,000  Vanilloid 2 agonist
0,515  0,004  CYP2B6 inhibitor
0,515  0,004  5 Hydroxytryptamine uptake stimulant
0,525  0,018  AR expression inhibitor
0,514  0,009  Sedative
0,505  0,010  Antihelmintic
0,510  0,020  Antineoplastic (pancreatic cancer)
0,495  0,012  Vascular (periferal) disease treatment
0,484  0,003  Posttraumatic stress disorder treatment
0,499  0,019  Proliferative diseases treatment
0,476  0,006  UGT2B7 substrate
0,499  0,033  Antipruritic, allergic
0,467  0,008  Melanin inhibitor
0,470  0,015  Antidiabetic symptomatic
0,478  0,026  Antifungal
0,497  0,050  Analgesic
0,471  0,025  Carcinogenic
0,481  0,036  Histamine release inhibitor
0,451  0,009  Abortion inducer
0,488  0,050  TNF expression inhibitor
0,454  0,017  DNA synthesis inhibitor
0,454  0,025  Mutagenic
0,443  0,016  Antineoplastic (liver cancer)
0,422  0,003  Movement disorders treatment
0,452  0,035  Respiratory analeptic
0,456  0,040  Cholesterol antagonist
0,453  0,037  Antithrombotic
0,450  0,037  Immunostimulant
0,440  0,028  Cytostatic
0,423  0,015  Skin irritative effect
0,417  0,024  Nitric oxide antagonist
0,395  0,006  Insulin secretagoues
0,410  0,021  Vasodilator
0,394  0,007  Antiviral (Influenza A)
0,411  0,027  Chemopreventive
0,450  0,066  Antineoplastic (breast cancer)
0,384  0,006  Renal failure treatment
0,431  0,055  Antileukemic
0,385  0,012  Interferon gamma antagonist
0,375  0,004  Cannabinoid CB2 receptor antagonist
0,384  0,013  Antiacne
0,410  0,041  Hepatic disorders treatment
0,381  0,014  Skin whitener
0,379  0,013  Antiviral (Influenza)
0,434  0,078  Antiarthritic
0,422  0,067  Calcium channel L-type activator
0,430  0,075  Cyclophilin D inhibitor
0,430  0,075  Antidiabetic
0,391  0,040  Analeptic
0,412  0,062  Antineoplastic (lung cancer)
0,368  0,018  Antiviral (HIV)
0,394  0,046  Immunomodulator
0,409  0,061  Atherosclerosis treatment
0,414  0,068  15-Lipoxygenase inhibitor
0,356  0,012  Acaricide
0,413  0,071  Antiparkinsonian
0,344  0,003  TRPM8 blocker
0,403  0,064  Antiobesity
0,363  0,025  UDP-glucuronosyltransferase substrate
0,347  0,013  Protein-tyrosine phosphatase inhibitor
0,335  0,009  DNA polymerase I inhibitor
0,421  0,099  Caspase 9 stimulant
0,358  0,037  Free radical scavenger
0,330  0,009  Protein-tyrosine phosphatase 1B inhibitor
0,322  0,015  Bone formation stimulant
0,358  0,051  Antineoplastic (melanoma)
0,321  0,017  Hair growth stimulant
0,344  0,044  Sodium/bile acid cotransporter inhibitor
0,330  0,031  Antihypertriglyceridemic
0,304  0,010  Antifungal enhancer
0,311  0,017  Phospholipase C inhibitor
0,343  0,055  Lipoprotein disorders treatment
0,304  0,028  Eye irritation, high
0,358  0,086  CYP2C19 inhibitor
0,284  0,013  UGT2B9 substrate
0,370  0,099  5 Hydroxytryptamine release inhibitor
0,334  0,065  Caspase 3 stimulant
0,330  0,061  NOS3 expression inhibitor
0,278  0,020  Protein kinase stimulant
0,329  0,072  ICAM1 expression inhibitor
0,312  0,059  Antihypercholesterolemic
0,260  0,008  Antifungal (Cryptococcus)
0,316  0,069  Antineoplastic (brain cancer)
0,303  0,056  Antineoplastic (cervical cancer)
0,305  0,059  UGT2B4 substrate
0,272  0,028  Antipruritic, non-allergic
0,330  0,086  CYP3A4 substrate
0,308  0,068  Interleukin 2 agonist
0,295  0,057  Amyotrophic lateral sclerosis treatment
0,305  0,071  Antineoplastic (ovarian cancer)
0,251  0,020  Antidiarrheal
0,288  0,058  Antiprotozoal (Leishmania)
0,267  0,038  VCAM1 expression inhibitor
0,278  0,049  Dependence treatment
0,286  0,058  Hypoglycemic
0,255  0,027  Carcinogenic, group 3
0,258  0,030  Antiviral (Herpes)
0,281  0,054  Cytotoxic
0,307  0,081  Apoptosis antagonist
0,234  0,015  Expectorant
0,286  0,066  Renal disease treatment
0,258  0,041  Hepatoprotectant
0,239  0,024  Genotoxic
0,246  0,033  Antihelmintic (Nematodes)
0,219  0,007  Actinic keratosis treatment
0,298  0,089  FMO1 substrate
0,314  0,105  CYP2C9 inhibitor
0,262  0,055  Antiulcerative
0,225  0,018  Neurotrophic factor
0,234  0,028  Phospholipase A2 inhibitor
0,244  0,043  Pneumotoxic
0,226  0,026  Neuropathy treatment
0,286  0,087  Antineoplastic (colorectal cancer)
0,276  0,078  Radioprotector
0,264  0,069  Tumour necrosis factor alpha release inhibitor
0,207  0,012  Aldehyde dehydrogenase substrate
0,195  0,002  Adenosine uptake inhibitor
0,267  0,074  UGT1A9 substrate
0,262  0,071  Antipyretic
0,213  0,024  Cholesterol synthesis inhibitor
0,249  0,062  UGT1A6 substrate
0,203  0,016  Alcohol dehydrogenase substrate
0,192  0,005  Ornithine decarboxylase inhibitor
0,230  0,044  Antimutagenic
0,294  0,111  Ulceration
0,252  0,071  Acute neurologic disorders treatment
0,278  0,100  Antihypertensive
0,215  0,038  Succinate dehydrogenase inhibitor
0,195  0,018  Choleretic
0,224  0,051  Insulin sensitizer
0,259  0,090  Antineoplastic (colon cancer)
0,260  0,091  Cardioprotectant
0,199  0,034  Arachidonic acid antagonist
0,203  0,037  Antiseptic
0,176  0,012  Transcription factor NF kappa B stimulant
0,166  0,002  Vanilloid 4 agonist
0,240  0,077  Platelet antagonist
0,172  0,009  Anabolic
0,179  0,025  Antineoplastic antibiotic
0,216  0,062  Neurotrophic factor enhancer
0,164  0,012  Cannabinoid receptor antagonist
0,171  0,022  UGT2B1 substrate
0,248  0,102  Lipoxygenase inhibitor
0,152  0,007  Glycine receptor agonist
0,162  0,017  Antibiotic
0,252  0,108  Prostate cancer treatment
0,155  0,013  HIV-1 integrase (3'-Processing) inhibitor
0,208  0,067  Platelet adhesion inhibitor
0,250  0,110  CTGF expression inhibitor
0,187  0,048  UGT2B10 substrate
0,147  0,010  TRPA1 antagonist
0,236  0,102  Antidiabetic (type 2)
0,190  0,056  UGT1A3 substrate
0,151  0,020  Electron transport complex I inhibitor
0,182  0,051  Antineoplastic (carcinoma)
0,167  0,037  Farnesoid X receptor antagonist
0,137  0,007  Ca(v)3.1 blocker
0,156  0,030  Antiemetic
0,127  0,003  Retinoid X receptor agonist
0,229  0,107  CYP1A2 inhibitor
0,129  0,008  5-Alpha-reductase inhibitor
0,164  0,043  Topoisomerase II inhibitor
0,143  0,024  Antiprotozoal (Toxoplasma)
0,190  0,071  P-glycoprotein inhibitor
0,208  0,089  Peptidyltransferase inhibitor
0,156  0,037  Growth stimulant
0,178  0,060  Prostate disorders treatment
0,183  0,066  Antineoplastic (gastric cancer)
0,145  0,028  Beta glucuronidase inhibitor
0,139  0,025  Antispirochetal
0,165  0,052  Pancreatic disorders treatment
0,211  0,098  Cardiovascular analeptic
0,129  0,022  Antiviral (Trachoma)
0,200  0,094  Hypolipemic
0,149  0,043  Autism spectrum disorders treatment
0,124  0,019  Peroxisome proliferator-activated receptor gamma agonist
0,120  0,016  HIV-1 integrase (Strand Transfer) inhibitor
0,200  0,099  RNA-directed DNA polymerase inhibitor
0,128  0,031  Antiviral (Coronavirus)
0,128  0,031  Antiviral (SARS coronavirus)
0,110  0,013  Cannabinoid CB1 receptor antagonist
0,120  0,025  Inducible nitric-oxide synthase inhibitor
0,147  0,051  Ca2+-transporting ATPase inhibitor
0,113  0,017  Leukotriene antagonist
0,219  0,126  Antipsoriatic
0,145  0,052  Antihyperlipoproteinemic
0,176  0,084  Sleep disorders treatment
0,220  0,129  CYP1A2 substrate
0,193  0,103  Antineoplastic (glioma)
0,152  0,064  Antineoplastic (squamous cell carcinoma)
0,251  0,163  Antiprotozoal
0,120  0,039  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,168  0,088  Antirickettsial
0,153  0,073  Acute respiratory distress syndrome (ARDS) treatment
0,102  0,023  SULT1A2 substrate
0,139  0,061  Interleukin 4 antagonist
0,093  0,015  Antimycoplasmal
0,108  0,032  CYP2A6 inhibitor
0,125  0,051  Photosensitizer
0,102  0,030  Glycine receptor antagonist
0,122  0,051  GABA C receptor antagonist
0,161  0,091  Lipocortins synthesis antagonist
0,098  0,029  CDC25A inhibitor
0,125  0,057  Antiviral (Influenza B)
0,210  0,141  Antimycobacterial
0,212  0,146  FMO3 substrate
0,069  0,004  Retinoid X receptor antagonist
0,153  0,091  Dual specificity phosphatase inhibitor
0,130  0,069  Antihemorrhagic
0,103  0,042  Bile acid receptor antagonist
0,069  0,009  Retinoid X alpha receptor agonist
0,100  0,040  ATPase (Vacuolar H+) inhibitor
0,205  0,146  Hypoxia-inducible factor 1 alpha inhibitor
0,110  0,052  Antihypermotility
0,094  0,037  Na+ K+ transporting ATPase inhibitor
0,117  0,060  Estrogen antagonist
0,107  0,051  Estrogen receptor beta antagonist
0,159  0,103  Septic shock treatment
0,106  0,050  UGT2B11 substrate
0,089  0,034  Lipase inhibitor
0,114  0,060  Mucolytic
0,105  0,051  Prolactin inhibitor
0,227  0,175  Calcium channel activator
0,071  0,019  Leukotriene B4 antagonist
0,145  0,094  Muscle relaxant
0,054  0,005  Retinoid X alpha receptor antagonist
0,083  0,035  Antitreponemal
0,098  0,050  Antithrombocytopenic
0,087  0,040  Keratolytic
0,136  0,089  NOS3 expression enhancer
0,151  0,104  Catenin beta inhibitor
0,109  0,063  Topoisomerase I inhibitor
0,114  0,068  Microtubule formation inhibitor
0,055  0,010  Kainate receptor agonist
0,048  0,005  Retinoic acid receptor agonist
0,101  0,059  Xanthine oxidase inhibitor
0,190  0,148  Transcription factor STAT3 inhibitor
0,108  0,069  SULT1A1 substrate
0,071  0,032  Hypercalcemia treatment
0,064  0,028  Protein 50S ribosomal subunit inhibitor
0,081  0,046  Estrogen receptor alpha antagonist
0,094  0,059  ABCA1 expression enhancer
0,049  0,015  Retinoic acid alpha receptor agonist
0,043  0,009  Protein 30S ribosomal subunit inhibitor
0,068  0,035  Neuraminidase inhibitor
0,169  0,136  Antineoplastic (renal cancer)
0,132  0,100  Sigma receptor agonist
0,072  0,042  Leukotriene synthesis inhibitor
0,069  0,041  Glutamate (mGluR6) antagonist
0,041  0,014  Tubulin agonist
0,049  0,022  Kainate receptor antagonist
0,065  0,038  Prostaglandin F2 alpha antagonist
0,044  0,017  Nicotinic acid receptor 2 agonist
0,040  0,013  ATP citrate lysase inhibitor
0,066  0,040  Neuraminidase (influenza) inhibitor
0,034  0,008  Retinoid X gamma receptor antagonist
0,094  0,069  5-Lipoxygenase inhibitor
0,059  0,034  Pregnane X receptor antagonist
0,038  0,013  Leukotriene B4 receptor 1 antagonist
0,031  0,006  Retinoic acid gamma receptor agonist
0,029  0,005  Retinoic acid beta receptor agonist
0,171  0,148  Interleukin agonist
0,058  0,035  Leukotriene C antagonist
0,032  0,010  Retinoid X gamma receptor agonist
0,198  0,177  Multiple sclerosis treatment
0,128  0,107  Adenylate cyclase stimulant
0,031  0,011  Nicotinic acid receptor 2 antagonist
0,096  0,076  AMP-activated protein kinase stimulant
0,023  0,003  Antibiotic Tetracycline-like
0,028  0,010  Leukotriene B4 receptor 2 antagonist
0,027  0,009  Retinoid X beta receptor agonist
0,048  0,030  Microtubule stabilization
0,188  0,170  Metabolic disease treatment
0,026  0,009  Retinoic acid alpha receptor antagonist
0,036  0,019  Calcium-independent phospholipase A2 inhibitor
0,024  0,008  Retinoid X beta receptor antagonist
0,052  0,037  Vanilloid 2 antagonist
0,062  0,048  CDC25B inhibitor
0,023  0,009  Retinoic acid receptor antagonist
0,109  0,095  Coagulant
0,026  0,012  Prostaglandin F2 alpha agonist
0,178  0,165  CYP2D6 substrate
0,054  0,041  Adenine nucleotide translocase inhibitor
0,115  0,102  UGT2B15 substrate
0,109  0,096  Antifungal (Pneumocystis)
0,125  0,113  Growth hormone agonist
0,035  0,025  Kainate receptor 2 antagonist
0,031  0,021  Prostaglandin D2 agonist
0,077  0,069  NMDA receptor antagonist
0,048  0,040  Factor III inhibitor
0,110  0,104  Lipid peroxidase inhibitor
0,134  0,127  Wound healing agent
0,063  0,058  Prostaglandin-E synthase inhibitor
0,034  0,029  Glutamate (mGluR8) antagonist
0,037  0,033  Leukotriene C4 antagonist
0,029  0,024  Prostaglandin agonist
0,029  0,025  Squalene synthetase inhibitor
0,021  0,018  Vitamin D receptor antagonist
0,011  0,009  Retinoic acid receptor gamma antagonist
0,029  0,028  Melatonin 2 agonist
0,043  0,043  Plasminogen activator inhibitor antagonist

